TrialJapanese journal of clinical oncology2020

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study.

Hiroyoshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.